4:41 PM ET
Form 4
Insider Buying
enGene Therapeutics Interim CMO William Grossman Buys $10.1K of Stock
William Grossman, Interim CMO, bought 5,102 shares of enGene Therapeutics Inc. at $1.97 a share, worth $10.1K in total on Sep 22, 2026. Shares held after the trade: 5,102.
- Value
- $10.1K
- Shares
- 5,102
- Price
- $1.97
- Role
- Interim CMO
- Trade date
- Sep 22, 2026